Also, the regulation of fibroblast growth factor markers, such as Fgf1 and Fgf4, as well as a subset of TGF‐β signaling markers showed more consistent upregulation in human IPF patients. The gene discussed is FGF4; the disease is idiopathic pulmonary fibrosis.